Appendix 3B - Proposed issue of securitiesAppendix 3B - Proposed issue of securities1 / 5Announcement SummaryEntity nameCAMBIUM BIO LIMITEDAnnouncement TypeNew announcementDate of this announcement8/10/2026The Proposed issue is:Total number of +securities proposed to be issued for a placement or...
Proposed issue of securities - CMB
Filed with ASX · · 5 pages · English
Release
Earlier from Cambium Bio
- Corporate Presentation - September 2026
- Date of AGM and Closing Date for Director Nominations
- Notification of cessation of securities - CMB
- Notification regarding unquoted securities - CMB
- Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye Disease
Later from Cambium Bio
- Notice of Annual General Meeting and Proxy form
- Access Letter and Online Meeting Guide
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio